Cambridge Investment Research Advisors
ALNT icon

Cambridge Investment Research Advisors’s Allient ALNT Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ALNT Stock Details ALNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$462K Buy
7,820
+638
+9% +$40.2K ﹤0.01% 2872
2025
Q4 		$386K Buy
+7,182
New +$376K ﹤0.01% 2960

Other funds holding ALNT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

Cambridge Investment Research Advisors's ALNT Position: Q1 2026 in Review

Cambridge Investment Research Advisors increased its Allient (ALNT) stake by 8.9% in Q1 2026, buying an estimated $40.2K and bringing the position to 7,820 shares worth $462K. The position accounts for ﹤0.01% of the portfolio, ranked #2872.

Cambridge Investment Research Advisors first reported a position in ALNT in Q4 2025 and has held it in 2 quarters since. 213 funds tracked by Wall St. Rank hold ALNT as of Q1 2026.

  • Cambridge Investment Research Advisors held 7,820 shares of Allient worth $462K as of Q1 2026.
  • Cambridge Investment Research Advisors bought 638 Allient shares in Q1 2026, an estimated $40.2K.
  • Allient made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #2872 holding.
  • Cambridge Investment Research Advisors first reported a position in Allient in Q4 2025 and has held it in 2 quarters since.
  • 213 funds tracked by Wall St. Rank held Allient as of Q1 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.